Key statistics
On Friday, Eton Pharmaceuticals Inc (ETON:NMQ) closed at 17.07, -25.78% below its 52-week high of 23.00, set on Sep 30, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 16.84 |
|---|---|
| High | 17.63 |
| Low | 16.79 |
| Bid | 16.77 |
| Offer | 18.20 |
| Previous close | 16.79 |
| Average volume | 268.75k |
|---|---|
| Shares outstanding | 26.82m |
| Free float | 25.62m |
| P/E (TTM) | -- |
| Market cap | 450.27m USD |
| EPS (TTM) | -0.2491 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Announcements
- Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
- Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results
- Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
- Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results
- Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
- Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes
- Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
- Eton Pharmaceuticals Reports First Quarter 2025 Financial Results
- Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
- Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
More ▼
